Wednesday May 23 | Stockopedia
Why big IPOs are the ultimate middle finger to investors
So they let a hoodie into the stock exchange and everyone got mugged. Well there's a surprise.
Merck profit beats forecast, revenue lags
New documents reveal stunning details on executive pay at Lehman Brothers, the failed Wall Street bank that helped trigger the financial crisis, the LA Times reports.
2 Biotech Stocks That Could Jump On Hepatitis C Breakthroughs
I believe the best investments in the biotech market are in companies focused on the treatment of chronic diseases.
Schering-Plough's productivity transformation programme to yield $1.5 billion annualised savings
Schering-Plough Corporation has announced a major new productivity transformation programme to reduce and avoid costs and increase productivity to generate a total of $1.5 billion in targeted annual savings and synergies - approximately 10 per cent of the combined company's full year 2007 estimated cost base, including Organon BioSciences and ... (more)
Merck to acquire Schering- Plough for $41 billion
In a season of epic pharmaceutical mergers, drug major Merck & Co. is acquuiring Schering-Plough Corp.